BlinatumomabCytokine release syndrome and immune-related pneumonia syndrome: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1858卷 / 1期

关键词：

D O I：

10.1007/s40278-021-96803-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：85 / 85

相关论文

共 50 条

[11] Camrelizumab/catequentinibGrade 2 immune-related pneumonia: case report
Reactions Weekly, 2022, 1903 (1) : 106 - 106
[12] BlinatumomabCytokine release syndrome and neurologic toxicity: 2 case reports
Reactions Weekly, 2020, 1787 (1) : 109 - 109
[13] BlinatumomabCytokine release syndrome and lack of efficacy: 4 case reports
Reactions Weekly, 2022, 1935 (1) : 120 - 120
[14] Susac's syndrome as an immune-related adverse event after pembrolizumab: a case report
De Groot, M.
Compter, A.
De Langen, A. J.
Brandsma, D.
JOURNAL OF NEUROLOGY, 2020, 267 (01) : 282 - 284
[15] Susac’s syndrome as an immune-related adverse event after pembrolizumab: a case report
M. De Groot
A. Compter
A. J. De Langen
D. Brandsma
Journal of Neurology, 2020, 267 : 282 - 284
[16] TisagenlecleucelCytokine release syndrome and immune related effector cell-associated neurotoxicity syndrome: case report
Reactions Weekly, 2023, 1959 (1) : 608 - 608
[17] Differentiating Immune-Related Adrenal Insufficiency From Low Cardiac Output Syndrome: A Case Report
Tanabe, Junya
Watanabe, Nobuhide
Ito, Mayuna
Kanasaki, Keizo
Tanabe, Kazuaki
CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (11)
[18] AntineoplasticsBone marrow suppression, hyperprogressive disease and immune-related pneumonia: case report
Reactions Weekly, 2021, 1848 (1) : 52 - 52
[19] AntineoplasticsLack of efficacy, cytokine release syndrome and immune effector cell-related neurotoxicity syndrome: case report
Reactions Weekly, 2022, 1909 (1) : 67 - 67
[20] AntineoplasticsLack of efficacy, immune-related hyperthermia and immune-related pneumonitis: case report
Reactions Weekly, 2021, 1864 (1) : 43 - 43

← 1 2 3 4 5 →